On the Antiquity of CancerEvidence for Metastatic Carcinoma in a Young Man from Ancient Nubia (c. 1200BC)

If cancer is a disease of modern living — of pollution, processed food, and a sedentary life — then it should be essentially absent in ancient remains. If it is absent in ancient remains, the archaeological record should be nearly silent on it. It is nearly silent. So, the reasoning holds. Unless you find a young man buried in northern Sudan three thousand years ago whose bones are riddled with tumors. And someone just did. The prevailing assumption in palaeopathology — the systematic study of disease in past human remains — has been that cancer's rarity in ancient skeletal collections reflects genuine rarity in ancient populations. The logic is clear: modern cancer rates have more than doubled over the past thirty years, and the rise is typically framed as a hallmark of industrialization, dietary change, pollution, and longer lifespans. Up to eighty percent of cancer-related deaths today are linked to modern lifestyle factors. If those factors barely existed before the industrial era, cancer should have barely existed either. But the biology of cancer complicates that story in a fundamental way. Most malignant tumors begin in soft tissue. Soft tissue doesn't survive burial. Primary bone cancers are rare even in modern populations, while the secondary bone involvement that comes from metastatic spread — cancer migrating from its origin to the skeleton — only becomes visible on bone surfaces in advanced stages, after it has eaten through the cancellous interior into the outer cortical shell. Add incomplete skeletal preservation, the fact that ancient remains are rarely radiographed, and the reasonable assumption that shorter average lifespans meant fewer age-associated cancers, and you get a record that looks empty. The question is whether that emptiness is real or whether it is mostly a gap in detection. One skeleton from a well-documented tomb in the Nile Valley has something important to say about that. Michaela Binder, Charlotte Roberts, Neal Spencer, Daniel Antoine, and Caroline Cartwright excavated the individual known as Skeleton 244-8 from tomb G244 at Amara West in 2013. Amara West sits on the left bank of the Nile about 750 kilometers downstream of modern Khartoum. It was founded around 1300 BC as an Egyptian colonial administrative center for the region of Kush, and the ceramic assemblage and tomb architecture place this particular burial within the Twentieth Dynasty — roughly 1187 to 1064 BC, or around 1200 BC. The tomb itself is architecturally hybrid: a Nubian tumulus mound above ground and Egyptian-style underground chambers below. The individual lay in a badly deteriorated painted wooden coffin, accompanied by a faience scaraboid, with the bones suggesting the body had been tightly wrapped. Standard osteological analysis of the pelvis and skull confirmed this was a male, and changes in the pubic symphysis and skeletal maturation markers put his age at death between twenty-five and thirty-five years. He was young. What Binder and colleagues found across his skeleton was unmistakable once they looked carefully. Multiple osteolytic lesions — areas of bone destruction caused by a resorptive disease process — appeared on the vertebrae, ribs, sternum, clavicles, scapulae, pelvis, and the heads of the humerus and femur. Osteolytic means bone-destroying: tumors that metastasize to bone typically do so by consuming the cancellous interior and eventually breaking through the cortex. The lesions in Skeleton 244-8 ranged from three to thirty millimeters across the scapulae, clavicles, sternum, vertebrae, and pelvis. Individual ribs showed clusters of lesions two to four millimeters in diameter, with one conspicuous elliptical focus on the left first rib measuring nine by six by four millimeters. Vertebral bodies showed lesions from five to twelve millimeters; one lesion had destroyed nearly the entire body of the seventh thoracic vertebra. The sternum showed at least seven sub-circular lesions measuring seven to twenty-eight millimeters on radiographs. The right femoral head carried seven cortical defects measuring five to eight millimeters. To map all of this, the team used four complementary tools: macroscopic examination, conventional radiography with a Seifert Isovolt DS1 X-ray tube, digital microscopy with a DinoLite Premier, and scanning electron microscopy with a Hitachi S-3700N variable pressure scanning electron microscope. The combination mattered. Radiography consistently revealed more and larger internal cavitations than were visible on the bone surface — exactly what you would expect when a disease starts in cancellous marrow and only later breaks through. Scanning electron microscope analysis of individual lesion margins revealed microscopic signs of osteoclastic activity, meaning the cells that normally remodel bone had been driven into destructive overdrive — an ante-mortem, disease-driven process, not post-mortem damage. Three alternative explanations had to be ruled out before that conclusion could stand, and the team worked through each one systematically. Multiple myeloma — a blood cancer that also destroys bone from marrow outward — was the most serious competitor. But myeloma lesions tend to be small, uniform, and spherical with clean edges, densely and regularly distributed, and they lack new bone formation because myeloma suppresses osteoblast activity. The lesions in Skeleton 244-8 were irregular in shape, variable in size, unevenly distributed, and several showed localized new bone formation within trabecular structures. That pattern does not fit myeloma. Fungal infections were evaluated next, since certain mycoses can produce lytic bone lesions. Mycotic lesions characteristically appear as resorptive fronts rather than discrete cavitations, show minimal new bone formation, and tend to cluster in the distal long bones and small bones of the hands and feet. The distribution here — concentrated in vertebrae, ribs, pelvis, sternum, clavicles, scapulae, and proximal limb heads, with no distal small-bone involvement — does not conform to fungal disease. Then there's taphonomy — the post-mortem damage done by insects, roots, water, and soil chemistry. Dermestid beetles and other bone-consuming insects can punch small round holes in bone that superficially resemble pathological lesions. The scanning electron microscope work was decisive here. Insect damage produces regular tunnels that traverse bone rather than expand internally, and insects have no preference for marrow-rich axial elements. Targeted scanning electron microscope analysis confirmed that some defects were indeed post-mortem, but others showed clear osteoclastic activity consistent with disease. The radiographic pattern — internal lesions larger and more numerous than surface defects — sealed the conclusion. Metastatic carcinoma, secondary to an unknown soft-tissue primary, is the most parsimonious diagnosis. This makes Skeleton 244-8 the earliest complete example in the world of a human who suffered metastatic cancer, as Binder and colleagues state. That is a significant claim, and the strength of the study rests on two things: the rigor of the differential diagnosis, which used every imaging tool available to eliminate the alternatives, and the quality of the archaeological context, which places this individual precisely in time and place. He is not a decontextualized bone. He is a young man from a specific town, a specific tomb, a specific moment in history. What does it mean? It does not overturn the idea that modern environments and longevity drive the modern cancer burden. Binder and colleagues are careful on this point. Shorter average lifespans in antiquity would have reduced time for age-associated cancers to develop. Taphonomic limits and the rarity of systematic radiography mean many ancient cancers were probably missed. The rarity in the record likely reflects both genuinely lower incidence and a detection gap. But the case does mean cancer is ancient, and it raises real questions about what caused it then. The authors point to carcinogens that predate industrialization: indoor wood smoke from hearths and ovens and the use of bitumen. They also raise infectious contributors — schistosomiasis has been present in Egypt and Nubia since at least 1500 BC and is now recognized as a driver of bladder cancer; Helicobacter pylori, linked to gastrointestinal malignancy, has ancient roots in human populations. This young man's cancer was almost certainly not caused by cigarettes or processed meat. Something else, possibly something endemic to his environment, drove the disease. The authors end with a forward-looking note that feels genuinely earned. Computed tomography, routine radiography of mummies, ancient DNA analysis, and other biomolecular approaches could identify cancer-associated mutations in ancient remains, map genomic changes against population history, and reveal soft-tissue primary tumors that leave no skeletal trace. The silence in the archaeological record is not a fixed feature. It is a function of the tools we have been using. The man from Amara West is a reminder that the disease was always there — waiting to be found by someone who looked carefully enough. This lecture was created by ennepō. Go to https://ennepo.ai to Discover, Create and Follow the latest research in your field. Read when you can. Listen when you want to.